Parmax Pharma Limited

PARMAX

Small Cap | Pharmaceuticals
33.25
-0.2 (-0.59%)

Stock price as on 06 Feb 2026 at 15:16 PM

Parmax pharma limited share price update

As of the latest trading session, Parmax Pharma Limited share price is currently at ₹33.25, which is down by ₹-0.2 from its previous closing. Today th...

Parmax Pharma Limited stock performance

Today’s low

₹33.25

Today’s high

₹33.25

₹33.25

52 week low

₹28

52 week high

₹55.02

₹33.25
Open
₹33.25
Previous close
₹33.45
Share volume
942
Total traded value (Lakh)
₹0.31
Upper circuit
₹40.14
Lower circuit
₹26.76

Parmax Pharma Limited fundamentals

Market cap (Cr)
₹12.40
P/E ratio (TTM)
-2.63
Book value per share
-₹14.81
Beta
-0.28
Return on equity
0%
Earnings per share (TTM)
₹0.00
Dividend yield
0%
Net profit/quarter (Cr)
-₹2.08

Parmax Pharma Limited financials

(Values in Cr)
Revenue
Net income

Particulars

Sep 25 (₹ value in crores)

Revenue

₹2.53

Operating expense

₹4.62

Net income

-₹2.08

Net profit margin

-82.21%

Earning per share

-₹5.56

EBITDA

-₹1.58

Effective tax rate

-

Particulars

Jun 25 (₹ value in crores)

Revenue

₹1.94

Operating expense

₹2.71

Net income

-₹0.76

Net profit margin

-39.17%

Earning per share

-₹2.04

EBITDA

-₹0.24

Effective tax rate

-

Particulars

Mar 25 (₹ value in crores)

Revenue

₹4.83

Operating expense

₹5.45

Net income

-₹1.49

Net profit margin

-30.84%

Earning per share

-₹4.00

EBITDA

-₹1.74

Effective tax rate

16.66%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹6.28

Operating expense

₹6.70

Net income

-₹0.39

Net profit margin

-6.21%

Earning per share

-₹1.05

EBITDA

₹0.12

Effective tax rate

-

Particulars

Sep 24 (₹ value in crores)

Revenue

₹9.28

Operating expense

₹9.61

Net income

-₹0.22

Net profit margin

-2.37%

Earning per share

-₹0.58

EBITDA

₹0.31

Effective tax rate

-

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹28.20

Operating expense

₹29.57

Net income

-₹2.09

Net profit margin

-7.41%

Earning per share

-₹5.60

EBITDA

-₹0.78

Effective tax rate

12.5%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹11.05

Operating expense

₹16.76

Net income

-₹5.75

Net profit margin

-52.03%

Earning per share

-₹15.37

EBITDA

-₹3.33

Effective tax rate

-1.59%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹15.42

Operating expense

₹15.42

Net income

-₹0.10

Net profit margin

-0.64%

Earning per share

-₹0.28

EBITDA

₹2.30

Effective tax rate

299.99%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹18.25

Operating expense

₹18.01

Net income

₹0.14

Net profit margin

0.76%

Earning per share

₹0.38

EBITDA

₹2.62

Effective tax rate

53.33%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹26.20

Operating expense

₹25.08

Net income

₹0.75

Net profit margin

2.86%

Earning per share

₹2.02

EBITDA

₹3.50

Effective tax rate

37.19%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

-₹4.47

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

-

EBITDA margin

1.06%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹0.24

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

1.9

EBITDA margin

-30.05%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹13.16

Return on Equity (ROE)

-1.69%

Return on Capital Employed (ROCE)

3.76%

Total debt to equity ratio

0.89

EBITDA margin

14.85%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹13.39

Return on Equity (ROE)

2.38%

Return on Capital Employed (ROCE)

6.04%

Total debt to equity ratio

0.94

EBITDA margin

14.41%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹13.07

Return on Equity (ROE)

13.79%

Return on Capital Employed (ROCE)

14.26%

Total debt to equity ratio

1.02

EBITDA margin

13.44%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹0.09

Total assets

₹18.75

Total liabilities

₹18.75

Total equity

-₹1.98

Shares outstanding

₹0.51

Price to book ratio

-₹9.45

Return on assets (%)

-11.16%

Return on capital

-36.64%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹0.05

Total assets

₹15.33

Total liabilities

₹15.33

Total equity

₹0.10

Shares outstanding

₹0.51

Price to book ratio

₹118.67

Return on assets (%)

-37.51%

Return on capital

-95.65%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.40

Total assets

₹17.61

Total liabilities

₹17.61

Total equity

₹5.85

Shares outstanding

-

Price to book ratio

₹2.31

Return on assets (%)

-0.59%

Return on capital

-1.01%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹1.05

Total assets

₹17.97

Total liabilities

₹17.97

Total equity

₹5.95

Shares outstanding

₹0.44

Price to book ratio

₹3.05

Return on assets (%)

0.78%

Return on capital

1.35%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹2.54

Total assets

₹22.72

Total liabilities

₹22.72

Total equity

₹5.81

Shares outstanding

₹0.44

Price to book ratio

₹2.72

Return on assets (%)

3.31%

Return on capital

6.7%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

-₹2.39

Cash from operations

-₹0.95

Cash from investing

-₹0.70

Cash from financing

₹1.39

Net change in cash

-₹0.26

Free cash flow

-₹0.25

Particulars

Mar 24 (₹ value in crores)

Net income

-₹5.65

Cash from operations

-₹0.19

Cash from investing

-₹1.58

Cash from financing

₹1.42

Net change in cash

-₹0.35

Free cash flow

₹1.39

Particulars

Mar 23 (₹ value in crores)

Net income

₹0.04

Cash from operations

₹0.33

Cash from investing

-₹0.93

Cash from financing

-₹0.04

Net change in cash

-₹0.64

Free cash flow

₹1.26

Particulars

Mar 22 (₹ value in crores)

Net income

₹0.30

Cash from operations

₹0.74

Cash from investing

-₹1.53

Cash from financing

-₹0.91

Net change in cash

-₹1.69

Free cash flow

₹2.28

Particulars

Mar 21 (₹ value in crores)

Net income

₹1.20

Cash from operations

₹3.52

Cash from investing

-₹3.14

Cash from financing

₹0.39

Net change in cash

₹0.77

Free cash flow

₹6.67

Parmax Pharma Limited technical summary

₹33.25
-0.59 ▼
1
Bearish
15
Bullish
5 Day33.5
10 Day33.8
12 Day33.9
20 Day34
26 Day34
50 Day33.9
100 Day34.3
200 Day35.7
5 Day33.4
10 Day33.8
12 Day33.8
20 Day34.8
26 Day34.5
50 Day33.7
100 Day33.2
200 Day36.8

34.13

PIVOT

First support
₹32.77
First resistance
₹34.82
Second support
₹32.08
Second resistance
₹36.18
Third support
₹30.72
Third resistance
₹36.87
RSI
48.61
ADX
14.99
MACD
-0.07
Williams % R
-70.63
Commodity Channel Index (CCI)
-54.2
Date
05 Feb 2026
Same day
1,407
Week
1,967
Month
1,617
1 year
-0.31
3 years
0.17
Over 1 month
-2.98%
Over 1 year
-23.1%
Over 3 months
1.36%
Over 3 years
-0.39%
Over 6 months
-10.75%
Over 6 years
1.56%

Investment Returns

Over 1 Month2.98%
Over 3 Months1.36%
Over 6 Months10.75%
Over 1 Year23.1%

Parmax Pharma Limited Shareholding pattern


Public
69.19%
Promoter holdings
30.8%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Alkesh Mahasukhlal Gopani

6,70,380 (17.92%)

Shareholding of Promoter and Promoter Group

Vipul Mahasukhlal Gopani

4,81,370 (12.87%)

Shareholding of Promoter and Promoter Group

Gosalia Meena Alkesh

4,74,800 (12.69%)

Public Shareholding

Pradeep Ramniklal Gosalia

3,02,714 (8.09%)

Public Shareholding

Umang Alkesh Gosalia

2,00,000 (5.35%)

Public Shareholding

Promoter sharesShareCategory
Alkesh Mahasukhlal Gopani6,70,380 (17.92%)Shareholding of Promoter and Promoter Group
Vipul Mahasukhlal Gopani4,81,370 (12.87%)Shareholding of Promoter and Promoter Group
Gosalia Meena Alkesh4,74,800 (12.69%)Public Shareholding
Pradeep Ramniklal Gosalia3,02,714 (8.09%)Public Shareholding
Umang Alkesh Gosalia2,00,000 (5.35%)Public Shareholding
Gosalia Nimit P90,000 (2.41%)Public Shareholding
Bharti Deepak Mehta42,816 (1.14%)Public Shareholding
Vandana Pradeepbhai Gosalia41,100 (1.1%)Public Shareholding
Pravina Mahasukhlal Gopani700 (0.02%)Shareholding of Promoter and Promoter Group

About Parmax Pharma Limited

Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk dru

Parent Organisation

Indian Private

NSE Symbol

Parmax Pharma Limited

Founded

1994

Parmax Pharma Limited CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)